Advertisement

European Spine Journal

, Volume 22, Issue 6, pp 1394–1401 | Cite as

The impact of fluorescence guidance on spinal intradural tumour surgery

  • Sven O. EickerEmail author
  • Frank W. Floeth
  • Marcel Kamp
  • Hans-Jakob Steiger
  • Daniel Hänggi
Original Article

Abstract

Purpose

5-Aminolevulinic acid (5-ALA)-based fluorescence-guided surgery was shown to be beneficial for cerebral malignant gliomas. Extension of this technique for resection of meningiomas and cerebral metastasis has been recently evaluated. Aim of the present study is to evaluate the impact of fluorescence-guided surgery in spinal tumor surgery.

Methods

Twenty-six patients with intradural spinal tumors were included in the study. 5-ALA was administered orally prior to the induction of anesthesia. Intraoperative, 440 nm fluorescence was applied after exploration of the tumor and, if positive, periodically during and at the end of resection to detect tumor-infiltrated sites.

Results

Tumors of WHO grade III and IV were found in five patients. In detail intra- or perimedullary metastasis of malignant cerebral gliomas was found including glioblastoma WHO grade IV (n = 2), anaplastic astrocytoma WHO grade III (n = 1), anaplastic oligoastrocytoma WHO grade III (n = 1). In addition, one patient suffered from a spinal drop metastasis of a cerebellar medulloblastoma WHO grade IV. Tumors of WHO grade I were diagnosed in 18 patients: Eight cases of meningioma (two recurrences), six cases of neurinoma, one neurofibroma, two ependymoma and one plexus papilloma. At least, benign pathologies were histologically proven in three patients. All four spinal metastasis of malignant glioma (100 %), seven of eight meningiomas (87.5 %) and one of two ependymoma (50 %) were found to be ALA-positive.

Conclusion

The present study demonstrates that spinal intramedullary gliomas and the majority of spinal intradural meningiomas are 5-ALA positive. As a surgical consequence, especially in intramedullary gliomas, the use of 5-ALA fluorescence seems to be beneficial.

Keywords

Fluorescence-guided surgery 5-Aminolevulinic acid (ALA) Spinal intradural tumor Spinal meningioma Spinal glioma Spinal neurinoma 

Notes

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Aghayev K, Vrionis F, Chamberlain MC (2011) Adult intradural primary spinal cord tumors. J Natl Compr Canc Netw 9:434–447PubMedGoogle Scholar
  2. 2.
    Alvisi C, Cerisoli M, Giulioni M (1984) Intramedullary spinal gliomas: long-term results of surgical treatments. Acta Neurochir (Wien) 70:169–179CrossRefGoogle Scholar
  3. 3.
    Arai T, Tani S, Isoshima A, Nagashima H, Joki T, Takahashi-Fujigasaki J, Abe T (2006) Intraoperative photodynamic diagnosis for spinal ependymoma using 5-aminolevulinic acid: technical note. No Shinkei Geka 34:811–817PubMedGoogle Scholar
  4. 4.
    Ciappetta P, Salvati M, Capoccia G, Artico M, Raco A, Fortuna A (1991) Spinal glioblastomas: report of seven cases and review of the literature. Neurosurgery 28:302–306PubMedCrossRefGoogle Scholar
  5. 5.
    Coluccia D, Fandino J, Fujioka M, Cordovi S, Muroi C, Landolt H (2010) Intraoperative 5-aminolevulinic-acid-induced flurescence in meningiomas. Acta Neurochir 152:711–719CrossRefGoogle Scholar
  6. 6.
    Ditunno JF, Donovan WH, Maynard FMASIAS, Ditunno JF (eds) (1994) Reference manual for the international standards for neurological and functional classification of spinal cord injury. ASIA, ChicagoGoogle Scholar
  7. 7.
    Eicker S, Sarikaya-Seiwert S, Borkhardt A, Gierga K, Turowski B, Heiroth HJ, Steiger HJ, Stummer W (2011) ALA-induced porphyrin accumulation in medulloblastoma and its use for fluorescence-guided surgery. Cen Eur Neurosurg 72:101–103CrossRefGoogle Scholar
  8. 8.
    El-Sharabasy MM, El-Waseef AM, Haffez MM, Salim SA (1992) Porphyrin metabolism in some malignant diseases. Br J Cancer 65:409–412PubMedCrossRefGoogle Scholar
  9. 9.
    Ewelt C, Stummer W, Klink B, Felsberg J, Steiger HJ, Sabel M (2010) Cordectomy as final treatment option for diffuse intramedullary malignant glioma using 5-ALA fluorescence-guided resection. Clin Neurol Neurosurg 112:357–361PubMedCrossRefGoogle Scholar
  10. 10.
    Ferreira NF, Barbosa M, Amaral LL, Mendonça RA, Lima SS (2004) Magnetic resonance imaging in 67 cases of glioblastoma multiforme and occurrence of metastases. Arq Neuropsiquiatr 62:695–700PubMedCrossRefGoogle Scholar
  11. 11.
    Fotinos N, Campo MA, Popowycz F, Gurny R, Lange N (2006) 5-Aminolevulinic acid derivatives in photomedicine: characteristics, application and perspective. Photochem Photobiol 82:994–1015PubMedCrossRefGoogle Scholar
  12. 12.
    Hautmann H, Pichler JP, Stepp H, Baumgartner R, Gamarra F, Huber RM (2007) In vivo kinetics of inhaled 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in bronchial tissue. Respir Res 8:33PubMedCrossRefGoogle Scholar
  13. 13.
    Hübner F, Braun V, Richter HP (2001) Case reports of symptomatic metastases in four patients with primary intracranial gliomas. Acta Neurochir (Wien) 143:25–29CrossRefGoogle Scholar
  14. 14.
    Hungerhuber E, Stepp H, Kriegmair M, Stief C, Hofstetter A, Hartmann A, Knuechel R, Karl A, Tritschler S, Zaak D (2007) Seven years’ experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder. Urology 69:260–264PubMedCrossRefGoogle Scholar
  15. 15.
    Kamp MA, Grosser P, Felsberg J, Slotty PJ, Steiger HJ, Reifenberger G, Sabel M (2012) 5-Aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochir (Wien) 154:223–228CrossRefGoogle Scholar
  16. 16.
    Klekamp J, Samii M (1999) Surgical results for spinal meningiomas. Surg Neurol 52:552–562PubMedCrossRefGoogle Scholar
  17. 17.
    Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109PubMedCrossRefGoogle Scholar
  18. 18.
    Moesta KT, Ebert B, Handke T, Nolte D, Nowak C, Haensch WE, Pandey RK, Dougherty TJ, Rinneberg H, Schlag PM (2001) Protoporphyrin IX occurs naturally in colorectal cancers and their metastases. Cancer Res 61:991–999PubMedGoogle Scholar
  19. 19.
    Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM (1997) 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 65:235–251PubMedCrossRefGoogle Scholar
  20. 20.
    Rapp M, Klingenhöfer M, Felsberg J, Steiger HJ, Stummer W, Sabel M (2012) Fluorescence-guided resection of spinal metastases of malignant glioma: report of 2 cases. J Neurol Surg A Cent Eur Neurosurg 73:103–105PubMedCrossRefGoogle Scholar
  21. 21.
    Shimizu S, Utsuki S, Sato K, Oka H, Fujii K, Mii K (2006) Photodynamic diagnosis in surgery for spinal ependymoma. Case illustration. J Neurosurg Spine 5:380PubMedCrossRefGoogle Scholar
  22. 22.
    Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39PubMedCrossRefGoogle Scholar
  23. 23.
    Slotty P Jr, Kröpil P, Klingenhöfer M, Steiger HJ, Hänggi D, Stummer W (2010) Preoperative localisation of spinal and peripheral pathologies for surgery by computed tomography-guided placement of a specialized needle system. Neurosurgery 66:784–787PubMedCrossRefGoogle Scholar
  24. 24.
    Solero CL, Fornari M, Giombini S, Lasio G, Oliveri G, Cimino C, Pluchino F (1989) Spinal meningioma: review of 174 operated cases. Neurosurgery 25:153–160PubMedCrossRefGoogle Scholar
  25. 25.
    Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003–1013PubMedCrossRefGoogle Scholar
  26. 26.
    Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, ALA-Glioma Study Group (2006) Fluorescence guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–401PubMedCrossRefGoogle Scholar
  27. 27.
    Stummer W, Stocker S, Novotny A, Heimann A, Sauer O, Kempski O, Plesnila N, Wietzorrek j, Reulen HJ (1998) In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. JPhotochem Photobiol B 45:160–169CrossRefGoogle Scholar
  28. 28.
    Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, Goetz AE, Kiefmann R, Reulen HJ (1998) Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 42:518–525PubMedCrossRefGoogle Scholar
  29. 29.
    Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, Rohde V, Oppel F, Turowski B, Woiciechowsky C, Franz K, Pietsch T, ALA-Glioma Study Group (2008) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564–576PubMedCrossRefGoogle Scholar
  30. 30.
    Sultan SM, El Doray AA, Hofstetter A, Abdel-Gawad O, El Mahdy A, Khoder W (2006) Photodynamic selectivity of 5-aminolevulinic acid to prostate cancer cells. J Egypt Natl Canc Inst 18:382–386PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Sven O. Eicker
    • 1
    Email author
  • Frank W. Floeth
    • 2
  • Marcel Kamp
    • 1
  • Hans-Jakob Steiger
    • 1
  • Daniel Hänggi
    • 1
  1. 1.Department of NeurosurgeryHeinrich-Heine-UniversityDüsseldorfGermany
  2. 2.Department of Spine and PainSt.-Vinzenz-HospitalDüsseldorfGermany

Personalised recommendations